SS-31 (elamipretide)
Also called elamipretide, ss31, bendavia
A peptide that targets mitochondria, approved in the US in 2025 for the rare disease Barth syndrome.
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.
What it is
SS-31 binds to cardiolipin, a fat in the inner membrane of mitochondria, and helps them make energy with less oxidative stress. As elamipretide it received accelerated approval in the US in 2025 for Barth syndrome, a rare genetic disease. Other uses, like healthy aging, are experimental.
How it’s used
- Injected under the skin once a day.
Typical amounts
- The approved dose for Barth syndrome is 40 mg once a day.
- Off-label amounts are often much lower; there is no established dose for other uses.
Good to know
- Injection-site reactions (redness, itching, pain) are very common.
- Outside Barth syndrome, the evidence is limited.
Educational information, not medical advice. Check anything you take with a doctor or pharmacist.